M
Mezzion Pharma Co Ltd
KOSDAQ:140410
Mezzion Pharma Co Ltd
KOSDAQ:140410
Price:
132 700
KRW
-1.63%
Market Cap:
₩4T
Balance Sheet
Balance Sheet Decomposition
Mezzion Pharma Co Ltd
Mezzion Pharma Co Ltd
Balance Sheet Decomposition is not available for
Mezzion Pharma Co Ltd
Mezzion Pharma Co Ltd
Balance Sheet
Mezzion Pharma Co Ltd
Mezzion Pharma Co Ltd
Currency: KRW
| Dec-2008 | Dec-2009 | Dec-2010 | Dec-2011 | Dec-2012 | Dec-2013 | Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||||||||
| Cash & Cash Equivalents |
900
|
6 713
|
11 829
|
11 077
|
20 106
|
29 793
|
39 354
|
65 334
|
20 594
|
30 890
|
26 750
|
15 644
|
35 854
|
24 210
|
29 399
|
40 246
|
13 617
|
|
| Cash |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
3 391
|
4 784
|
7 273
|
7 271
|
4 442
|
1 906
|
2
|
1
|
1
|
1
|
|
| Cash Equivalents |
900
|
6 713
|
11 829
|
11 077
|
20 106
|
29 793
|
39 354
|
61 943
|
15 810
|
23 617
|
19 479
|
11 202
|
33 948
|
24 208
|
29 398
|
40 246
|
13 616
|
|
| Short-Term Investments |
0
|
0
|
8 463
|
6 569
|
39 464
|
24 640
|
29 233
|
27 831
|
68 462
|
30 871
|
28 320
|
25 515
|
13 250
|
23 000
|
3 000
|
18 000
|
15 000
|
|
| Total Receivables |
253
|
677
|
136
|
354
|
0
|
3 350
|
2 561
|
2 033
|
2 462
|
2 091
|
6 620
|
4 399
|
4 248
|
4 591
|
4 363
|
6 031
|
1 757
|
|
| Accounts Receivables |
228
|
591
|
136
|
354
|
0
|
1 412
|
1 859
|
1 555
|
1 495
|
1 800
|
2 031
|
3 030
|
2 616
|
2 458
|
2 677
|
2 646
|
1 143
|
|
| Other Receivables |
25
|
86
|
0
|
0
|
0
|
1 938
|
702
|
478
|
967
|
291
|
4 589
|
1 369
|
1 632
|
2 132
|
1 686
|
3 385
|
614
|
|
| Inventory |
0
|
0
|
0
|
0
|
0
|
455
|
2 268
|
2 051
|
2 406
|
2 737
|
2 400
|
6 003
|
7 011
|
11 777
|
8 835
|
5 742
|
5 420
|
|
| Other Current Assets |
15
|
528
|
2
|
193
|
2
|
2
|
92
|
80
|
270
|
3 912
|
5 929
|
288
|
306
|
597
|
300
|
4 224
|
6 132
|
|
| Total Current Assets |
1 168
|
7 918
|
20 430
|
18 192
|
59 571
|
58 239
|
73 507
|
97 329
|
94 194
|
70 501
|
70 019
|
51 849
|
60 669
|
64 174
|
45 897
|
74 244
|
41 926
|
|
| PP&E Net |
210
|
117
|
125
|
173
|
183
|
142
|
315
|
749
|
203
|
861
|
1 200
|
4 902
|
5 899
|
4 879
|
4 245
|
2 854
|
2 529
|
|
| PP&E Gross |
210
|
117
|
125
|
173
|
0
|
142
|
315
|
749
|
203
|
861
|
1 200
|
4 902
|
5 899
|
4 879
|
4 245
|
2 854
|
2 529
|
|
| Accumulated Depreciation |
269
|
364
|
366
|
348
|
0
|
441
|
519
|
634
|
441
|
468
|
693
|
1 877
|
2 354
|
3 845
|
5 725
|
3 299
|
4 101
|
|
| Intangible Assets |
0
|
0
|
824
|
978
|
1 084
|
1 084
|
2 322
|
1 826
|
307
|
1 635
|
1 635
|
1 620
|
8 242
|
14 179
|
1 620
|
12 943
|
28 439
|
|
| Goodwill |
0
|
0
|
0
|
0
|
0
|
0
|
705
|
705
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Note Receivable |
0
|
0
|
0
|
0
|
0
|
0
|
263
|
293
|
332
|
487
|
223
|
30
|
160
|
30
|
310
|
150
|
280
|
|
| Long-Term Investments |
0
|
4 988
|
9 524
|
10 650
|
5 684
|
3 061
|
0
|
2 015
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Long-Term Assets |
151
|
1 841
|
663
|
1 589
|
780
|
814
|
762
|
135
|
863
|
554
|
1 983
|
472
|
656
|
673
|
1 950
|
1 958
|
824
|
|
| Other Assets |
0
|
0
|
0
|
0
|
0
|
0
|
705
|
705
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Assets |
1 529
N/A
|
14 864
+872%
|
31 567
+112%
|
31 582
+0%
|
67 302
+113%
|
63 340
-6%
|
77 875
+23%
|
103 052
+32%
|
95 899
-7%
|
74 038
-23%
|
75 059
+1%
|
58 874
-22%
|
75 625
+28%
|
83 935
+11%
|
54 022
-36%
|
92 149
+71%
|
73 998
-20%
|
|
| Liabilities | ||||||||||||||||||
| Accounts Payable |
0
|
0
|
0
|
0
|
688
|
0
|
5
|
2 242
|
3 444
|
2 469
|
2 993
|
3 574
|
3 466
|
5 503
|
7 173
|
4 030
|
1 646
|
|
| Accrued Liabilities |
95
|
244
|
165
|
97
|
0
|
79
|
276
|
124
|
837
|
4 919
|
7 641
|
7 850
|
5 533
|
7 188
|
11 472
|
21 831
|
18 882
|
|
| Short-Term Debt |
1 500
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
425
|
985
|
932
|
1 063
|
500
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
8 175
|
239
|
753
|
1 015
|
1 051
|
1 026
|
736
|
694
|
|
| Other Current Liabilities |
569
|
2 341
|
4 321
|
1 265
|
2 257
|
57
|
10 421
|
11 354
|
12 200
|
4 930
|
6 868
|
908
|
4 515
|
3 823
|
5 346
|
2 519
|
5 447
|
|
| Total Current Liabilities |
2 164
|
2 585
|
4 486
|
1 362
|
2 945
|
136
|
10 703
|
13 720
|
16 481
|
20 493
|
17 740
|
13 510
|
15 514
|
18 497
|
26 080
|
29 615
|
26 670
|
|
| Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
25 236
|
26 255
|
0
|
0
|
2 420
|
3 104
|
2 338
|
1 625
|
1 005
|
921
|
|
| Deferred Income Tax |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
147
|
354
|
376
|
0
|
0
|
0
|
0
|
0
|
0
|
251
|
|
| Other Liabilities |
4 103
|
4 029
|
2 253
|
2 051
|
1 021
|
1 026
|
1 021
|
1 413
|
0
|
0
|
0
|
114
|
198
|
307
|
77
|
85
|
92
|
|
| Total Liabilities |
6 267
N/A
|
6 614
+6%
|
6 740
+2%
|
3 413
-49%
|
3 966
+16%
|
1 163
-71%
|
11 724
+908%
|
40 516
+246%
|
43 090
+6%
|
20 869
-52%
|
17 740
-15%
|
16 044
-10%
|
18 816
+17%
|
21 141
+12%
|
27 782
+31%
|
30 705
+11%
|
27 935
-9%
|
|
| Equity | ||||||||||||||||||
| Common Stock |
1 526
|
3 026
|
3 026
|
3 026
|
4 040
|
4 040
|
4 059
|
4 079
|
4 079
|
4 171
|
4 321
|
4 353
|
4 446
|
4 451
|
13 371
|
14 804
|
14 982
|
|
| Retained Earnings |
11 716
|
147
|
16 318
|
19 623
|
21 694
|
20 503
|
17 826
|
21 857
|
9 905
|
5 125
|
24 113
|
47 351
|
61 166
|
74 789
|
111 052
|
123 723
|
143 148
|
|
| Additional Paid In Capital |
5 452
|
5 444
|
5 444
|
5 444
|
51 332
|
51 616
|
53 029
|
52 509
|
54 800
|
63 366
|
64 136
|
67 283
|
92 836
|
88 249
|
79 704
|
130 958
|
139 509
|
|
| Unrealized Security Profit/Loss |
0
|
73
|
0
|
0
|
0
|
0
|
0
|
0
|
8
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Treasury Stock |
0
|
0
|
0
|
0
|
0
|
14 004
|
8 763
|
16 816
|
16 816
|
8 708
|
1 240
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Equity |
0
|
0
|
40
|
78
|
13 730
|
23
|
0
|
909
|
834
|
535
|
14 216
|
18 546
|
20 694
|
44 882
|
44 218
|
39 406
|
34 720
|
|
| Total Equity |
4 738
N/A
|
8 249
N/A
|
24 828
+201%
|
28 170
+13%
|
63 336
+125%
|
62 177
-2%
|
66 151
+6%
|
62 537
-5%
|
52 809
-16%
|
53 169
+1%
|
57 319
+8%
|
42 830
-25%
|
56 810
+33%
|
62 793
+11%
|
26 240
-58%
|
61 444
+134%
|
46 063
-25%
|
|
| Total Liabilities & Equity |
1 529
N/A
|
14 864
+872%
|
31 567
+112%
|
31 582
+0%
|
67 302
+113%
|
63 340
-6%
|
77 875
+23%
|
103 052
+32%
|
95 899
-7%
|
74 038
-23%
|
75 059
+1%
|
58 874
-22%
|
75 625
+28%
|
83 935
+11%
|
54 022
-36%
|
92 149
+71%
|
73 998
-20%
|
|
| Shares Outstanding | ||||||||||||||||||
| Common Shares Outstanding |
8
|
8
|
8
|
8
|
7
|
7
|
8
|
7
|
7
|
8
|
9
|
9
|
9
|
27
|
27
|
30
|
30
|
|
Switch to:
Switch to:
See Also
Discover More
